The targets of ESG investors are all worthwhile but do not take much courage. Why not also go after excessive executive compensation or nasty political regimes?
(17-Dec-2018)
ESG groupthink has captured the fund industry
On October 1, the Delaware Court of Chancery denied a motion to dismiss a
Caremark claim in In re Clovis Oncology, Inc. Derivative Litigation.
Under In re ...
18 hours ago
0 comments:
Post a Comment